Dr. Reddy’s Laboratories Limited (REDY) – New products and innovations leads to growth

in , on July 12, 2021

Remdesivir was launched in India and have ramped up supplies to meet with the higher demand due to surge of the COVID cases in India. Avigan ® is being sold in India and few other markets. The company is conducting phase 3 trials in North America for outpatient setting with mild to moderate symptoms.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– DCF Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

No of Pages : 34

Release Information

  • Price
    :

    $99.00

  • Released
    :

    July 12, 2021

  • Last Updated
    :

    July 14, 2021